Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023
Unregistered and/or falsified medicines were present in all premise types, with higher prevalence in commercial premises. Enhanced efforts by enforcement authorities and stakeholders are necessary to improve the quality of medicine in Malaysia.
Authors
- Nor I A Muhsin (ORCID: https://orcid.org/0000-0003-1525-5068)
- Asniza Alias
- Ayaz Ahmad (ORCID: https://orcid.org/0000-0003-4271-5170)
- Moha Asri Abdullah (ORCID: https://orcid.org/0000-0002-5178-2300)
- Marizan Sulaiman (ORCID: https://orcid.org/0000-0002-2117-8874)
- Kelvin Karim
- Salina Setan
Institutions
- Universiti Malaysia Pahang Al-Sultan Abdullah (MY)
- Ministry of Health (MY)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1080/20523211.2025.2557879
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00